Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Fibrinogen Replacement Underutilization in ECMO

Lisa N Boggio, MD MS, Mindy L. Simpson, MD

Blood (2020) 136 (Supplement 1): 4–5.

https://doi.org/10.1182/blood-2020-142812

Published: 2020

Journal Articles

Thrombotic Events with NovoSeven ® RT in Approved Indications Are Rare (0.2%) and Associated with Older Age (>= 65 y), Cardiovascular Disease, and Concomitant Use of aPCCs

Madhvi Rajpurkar, MD, Stacy E. Croteau, MD, Lisa N Boggio, MD MS, David L Cooper, MD

Blood (2018) 132 (Supplement 1): 1203.

https://doi.org/10.1182/blood-2018-99-115153

Published: 2018

Journal Articles

Red Cell Exchange: A Concise Review of Indications and Management

Elizabeth Biller, Yong Zhao, Lejla Music-Aplenc, MD, Mary Berg, MD, Lisa N Boggio, MD MS, Theresa Boyd, Kelley Capocelli, Deanna C Fang, Scott A Koepsell, MD, PhD, FCAP, Huy P. Pham, MD, M.P.H., Angela Treml, John Weiss, Geoffrey D. Wool, MD PhD, Beverly W Baron

Blood (2017) 130 (Supplement 1): 4800.

https://doi.org/10.1182/blood.V130.Suppl_1.4800.4800

Published: 2017

Journal Articles

Dosing Factor in Pediatric and Adult Hemophilia Patients Using Ideal Body Weight Versus actual Body Weight

Adam P Kidwell, BS, Nidhi Bhatt, MD, Mindy L Simpson, MD FAAP, Lisa N Boggio, MD MS

Blood (2016) 128 (22): 4958.

https://doi.org/10.1182/blood.V128.22.4958.4958

Published: 2016

Journal Articles

Linear and Logistic Regression Models of Patient-Reported Outcomes and Patient Characteristics in US Adults with Hemophilia from the Pain, Functional Impairment, and Quality of Life (P-FiQ) Study

Katharine Batt, MD MSc, Michael Recht, MD PhD, Michael Wang, MD, Doris V. Quon, MD PhD, Lisa N Boggio, MD MS, Craig M. Kessler, MD, Tyler W. Buckner, MD MSc, Anne T. Neff, MD, Neeraj N Iyer, PhD, David L Cooper, MD MBA, Christine L Kempton, MD MSc

Blood (2016) 128 (22): 252.

https://doi.org/10.1182/blood.V128.22.252.252

Published: 2016

Journal Articles

Effectiveness of DDAVP in Von Willebrand’s Disease.

Lakshmi Balasubramanian, MD, Lisa N. Boggio, MD, Nancy Foiles, David Green, MD, PhD

Blood (2004) 104 (11): 4031.

https://doi.org/10.1182/blood.V104.11.4031.4031

Published: 2004

NARROW

Fibrinogen Replacement Underutilization in ECMO

Thrombotic Events with NovoSeven ® RT in Approved Indications Are Rare (0.2%) and Associated with Older Age (>= 65 y), Cardiovascular Disease, and Concomitant Use of aPCCs

Red Cell Exchange: A Concise Review of Indications and Management

Dosing Factor in Pediatric and Adult Hemophilia Patients Using Ideal Body Weight Versus actual Body Weight

Linear and Logistic Regression Models of Patient-Reported Outcomes and Patient Characteristics in US Adults with Hemophilia from the Pain, Functional Impairment, and Quality of Life (P-FiQ) Study

Effectiveness of DDAVP in Von Willebrand’s Disease.

Email alerts

ASH Publications

American Society of Hematology

Fibrinogen Replacement Underutilization in ECMO

Thrombotic Events with NovoSeven ® RT in Approved Indications Are Rare (0.2%) and Associated with Older Age (>= 65 y), Cardiovascular Disease, and Concomitant Use of aPCCs

Red Cell Exchange: A Concise Review of Indications and Management

Dosing Factor in Pediatric and Adult Hemophilia Patients Using Ideal Body Weight Versus actual Body Weight

Linear and Logistic Regression Models of Patient-Reported Outcomes and Patient Characteristics in US Adults with Hemophilia from the Pain, Functional Impairment, and Quality of Life (P-FiQ) Study

Effectiveness of DDAVP in Von Willebrand’s Disease.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only